---
title: "Glibornuride - Diabetes mellitus type 2"
sidebar: mydoc_sidebar
permalink: db08962-mesh-d003924-1.html
toc: false 
---


Path ID: `DB08962_MESH_D003924_1`
{% include image.html url="images/db08962-mesh-d003924-1.png" file="db08962-mesh-d003924-1.png" alt="db08962-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C073323 | Glibornuride | Drug |
| UniProt:Q14654 | ATP-sensitive inward rectifier potassium channel 11 | Protein |
| GO:0060081 | Membrane hyperpolarization | BiologicalProcess |
| GO:0070509 | Transmembrane calcium influx | BiologicalProcess |
| GO:0030073 | Insulin secretion | BiologicalProcess |
| HP:0003074 | Hyperglycemia | PhenotypicFeature |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Glibornuride | DECREASES ACTIVITY OF | Atp-Sensitive Inward Rectifier Potassium Channel 11 |
| Atp-Sensitive Inward Rectifier Potassium Channel 11 | PARTICIPATES IN | Membrane Hyperpolarization |
| Membrane Hyperpolarization | NEGATIVELY REGULATES | Transmembrane Calcium Influx |
| Transmembrane Calcium Influx | POSITIVELY REGULATES | Insulin Secretion |
| Insulin Secretion | NEGATIVELY CORRELATED WITH | Hyperglycemia |
| Hyperglycemia | MANIFESTATION OF | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Comment: Withdrawn. Glibornuride is a sulfonylurea-type anti-diabetic drug.

Reference: 
  - [https://go.drugbank.com/drugs/DB08962](https://go.drugbank.com/drugs/DB08962)
  - [https://en.wikipedia.org/wiki/Sulfonylurea](https://en.wikipedia.org/wiki/Sulfonylurea)

Reference: 
  - [https://go.drugbank.com/drugs/DB08962](https://go.drugbank.com/drugs/DB08962)
  - [https://en.wikipedia.org/wiki/Sulfonylurea](https://en.wikipedia.org/wiki/Sulfonylurea)
